You are here:Home1/Subclinical Thyroid Dysfunctions and Pregnancy and Neonatal Outcomes (...
Shahid Beheshti University of Medical Sciences Research Institute For Endocrine Sciences
Principal Investigator: Fahimeh Ramezani Tehrani
Professor of Obstetrics, Gynaecology and Reproductive Health -Shahid Beheshti University of Medical Sciences- Director, Reproductive Endocrinology Research Center, Research Institute for Endocrine Sciences
June 11, 2013
June 11, 2013
To identify the prevalence of subclinical thyroid dysfunction in pregnancy (phase 1) and assessment of the effect of Levothyroxine on pregnancy outcomes of pregnant women with subclinical thyroid dysfunction
Pregnant women attending prenatal clinics under coverage of Shahid Beheshti University of Medical Sciences, Tehran, Iran
Sampling method and sample size
First phase: Stratified, multistage probability cluster sampling method (n=3000). Second phase: Randomized clinical trial; number of sample for each group=200
Interview, questionnaire, physical exam, collecting of blood and urine samples for assessment of serum levels of TSH, T4, T3uptake and TPOab and urinary iodine
Follow up Methods
– Active fallow-up every 3 months to repeat all measurements.
– Active follow up delivery and/or hospitalized events.
Serum levels of TSH, T4, T3 Uptake, TPO Ab and urinary Iodine